Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 280: C1375-C1386, 2001;
0363-6143/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (79)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zachary, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zachary, I.
Vol. 280, Issue 6, C1375-C1386, June 2001

INVITED REVIEW
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor

Ian Zachary

Department of Medicine, University College London, London WC1E 6JJ, United Kingdom

Vascular endothelial growth factor (VEGF) is essential for angiogenesis in health and pathophysiology, and it is currently a major focus for drug targeting in the development of treatments for diverse human diseases. Recently, we proposed that VEGF could also play a role as a vascular protective factor in the adult vasculature and in disease. In this model, vascular protection is defined as a VEGF-induced enhancement of endothelial functions that mediate the inhibition of vascular smooth muscle cell proliferation, enhanced endothelial cell survival, suppression of thrombosis, and anti-inflammatory effects. A feature of this model is that protective effects of VEGF are essentially independent of angiogenesis or endothelial cell proliferation. VEGF-dependent cell survival and VEGF-induced synthesis of nitric oxide and prostacyclin are likely to be key mediators of a vascular protective effect. Vascular protection should help to improve insight into the underlying mechanisms of cardiovascular actions of VEGF and prove valuable for developing novel therapeutic approaches to cardiovascular disease.

angiogenesis; prostacyclin; nitric oxide; kinase domain receptor; apoptosis; endothelium


This article has been cited by other articles:


Home page
 BloodHome page
A. R. Kinderlerer, I. Pombo Gregoire, S. S. Hamdulay, F. Ali, R. Steinberg, G. Silva, N. Ali, B. Wang, D. O. Haskard, M. P. Soares, et al.
Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin
Blood, February 12, 2009; 113(7): 1598 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
V. C. Sandrim, A. C. T. Palei, R. C. Cavalli, F. M. Araujo, E. S. Ramos, G. Duarte, and J. E. Tanus-Santos
Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension
Mol. Hum. Reprod., February 1, 2009; 15(2): 115 - 120.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. R. Nalluri, D. Chu, R. Keresztes, X. Zhu, and S. Wu
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients: A Meta-analysis
JAMA, November 19, 2008; 300(19): 2277 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
B. A. Bryan, T. E. Walshe, D. C. Mitchell, J. S. Havumaki, M. Saint-Geniez, A. S. Maharaj, A. E. Maldonado, and P. A. D'Amore
Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation
Mol. Biol. Cell, March 1, 2008; 19(3): 994 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y.-L. Lin, Y.-C. Liang, and B.-L. Chiang
Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells
J. Leukoc. Biol., December 1, 2007; 82(6): 1473 - 1480.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Z. Li, Y. Zhang, J. Ying Ma, A. M. Kapoun, Q. Shao, I. Kerr, A. Lam, G. O'Young, F. Sannajust, P. Stathis, et al.
Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia
Hypertension, October 1, 2007; 50(4): 686 - 692.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Hasegawa, H. Takano, K. Iwanaga, M. Ohtsuka, Y. Qin, Y. Niitsuma, K. Ueda, T. Toyoda, H. Tadokoro, and I. Komuro
Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 842 - 849.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. J. Hicklin and L. M. Ellis
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. D. Longo and W. J. Pearce
Fetal cerebrovascular acclimatization responses to high-altitude, long-term hypoxia: a model for prenatal programming of adult disease?
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R16 - R24.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Dikov, J. E. Ohm, N. Ray, E. E. Tchekneva, J. Burlison, D. Moghanaki, S. Nadaf, and D. P. Carbone
Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation
J. Immunol., January 1, 2005; 174(1): 215 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Kallapur, C. J. Bachurski, T. D. L. Cras, S. N. Joshi, M. Ikegami, and A. H. Jobe
Vascular changes after intra-amniotic endotoxin in preterm lamb lungs
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1178 - L1185.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Shimizu, Y. Masuda, T. Mori, H. Kitamura, M. Ishizaki, Y. Sugisaki, and Y. Fukuda
Vascular Endothelial Growth Factor165 Resolves Glomerular Inflammation and Accelerates Glomerular Capillary Repair in Rat Anti-Glomerular Basement Membrane Glomerulonephritis
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2655 - 2665.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. C. Mason, R. Steinberg, E. A. Lidington, A. R. Kinderlerer, M. Ohba, and D. O. Haskard
Decay-accelerating Factor Induction on Vascular Endothelium by Vascular Endothelial Growth Factor (VEGF) Is Mediated via a VEGF Receptor-2 (VEGF-R2)- and Protein Kinase C-{alpha}/{epsilon} (PKC{alpha}/{epsilon})-dependent Cytoprotective Signaling Pathway and Is Inhibited by Cyclosporin A
J. Biol. Chem., October 1, 2004; 279(40): 41611 - 41618.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
L. Ye, H. K Haider, S.-J. Jiang, and E. K. Sim
Therapeutic Angiogenesis Using Vascular Endothelial Growth Factor
Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 173 - 181.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
N. Ferrara
Vascular Endothelial Growth Factor as a Target for Anticancer Therapy
Oncologist, June 1, 2004; 9(suppl_1): 2 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Seeliger, M. Guba, G. E. Koehl, A. Doenecke, M. Steinbauer, C. J. Bruns, C. Wagner, E. Frank, K.-W. Jauch, and E. K. Geissler
Blockage of 2-Deoxy-D-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy
Clin. Cancer Res., March 1, 2004; 10(5): 1843 - 1852.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. A.U. Heilmann, T. Attmann, A. Thiem, E. Haffner, F. Beyersdorf, and G. Lutter
Gene therapy in cardiac surgery: intramyocardial injection of naked plasmid DNA for chronic myocardial ischemia
Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 785 - 793.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. G. Seipelt, C. L. Backer, C. Mavroudis, V. Stellmach, I. M. Seipelt, M. Cornwell, J. Hernandez, and S. E. Crawford
Topical VEGF Enhances Healing of Thoracic Aortic Anastomosis for Coarctation in a Rabbit Model
Circulation, September 9, 2003; 108(90101): II-150 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Haskell, M. Natarajan, T. P. Hecker, Q. Ding, J. Stewart Jr., J. R. Grammer, and C. L. Gladson
Focal Adhesion Kinase Is Expressed in the Angiogenic Blood Vessels of Malignant Astrocytic Tumors in Vivo and Promotes Capillary Tube Formation of Brain Microvascular Endothelial Cells
Clin. Cancer Res., June 1, 2003; 9(6): 2157 - 2165.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. A.U. Heilmann, T. Attmann, P. von Samson, H. Gobel, D. Marme, F. Beyersdorf, and G. Lutter
Transmyocardial laser revascularization combined with vascular endothelial growth factor121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up?
Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 74 - 80.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
M. Rajasekaran, A. Kasyan, W. Allilain, and M. Monga
Ex Vivo Expression of Angiogenic Growth Factors and Their Receptors in Human Penile Cavernosal Cells
J Androl, January 1, 2003; 24(1): 85 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Z. He, C. Rask-Madsen, and G.L. King
Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. Rivilis, M. Milkiewicz, P. Boyd, J. Goldstein, M. D. Brown, S. Egginton, F. M. Hansen, O. Hudlicka, and T. L. Haas
Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1430 - H1438.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. D. Le Cras, N. E. Markham, R. M. Tuder, N. F. Voelkel, and S. H. Abman
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L555 - L562.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. V. Alvarez-Arroyo, S. Yague, R. M. Wenger, D. S. Pereira, S. Jimenez, F. R. Gonzalez-Pacheco, M. A. Castilla, J. J. P. Deudero, and C. Caramelo
Cyclophilin-Mediated Pathways in the Effect of Cyclosporin A on Endothelial Cells: Role of Vascular Endothelial Growth Factor
Circ. Res., August 9, 2002; 91(3): 202 - 209.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-M. Kim, Y.-M. Kim, Y. M. Lee, H.-S. Kim, J. D. Kim, Y. Choi, K.-W. Kim, S.-Y. Lee, and Y.-G. Kwon
TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial Cells
J. Biol. Chem., February 22, 2002; 277(9): 6799 - 6805.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
J.N. UPALAKALIN, I. HEMO, C. DEHIO, E. KESHET, and L.E. BENJAMIN
Survival Mechanisms of VEGF and PlGF during Microvascular Remodeling
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 181 - 188.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. S. Marchand, N. Noiseux, J.-F. Tanguay, and M. G. Sirois
Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H194 - H204.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. S. Goligorsky
Vascular endothelial growth factor: molecular underpinning from development of vasculature to development of disease
Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1357 - C1357.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. C. Mason, E. A. Lidington, S. R. Ahmad, and D. O. Haskard
bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction
Am J Physiol Cell Physiol, March 1, 2002; 282(3): C578 - C587.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online